- Zacks
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
- PR Newswire
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
- Zacks
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
© 2024 Yahoo. All rights reserved.